[1]
“COMMUNITY-ACQUIRED PNEUMONIA: IMMUNE AND METABOLIC DISORDERS BEFORE AND AFTER TREATMENT”, Journal of Pharmaceutical Negative Results, pp. 997–1003, Sep. 2022, Accessed: Jun. 20, 2026. [Online]. Available: https://www.pnrjournal.com/index.php/home/article/view/1013